• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Kyverna swaps CEOs, leaning on Kite veterans to lead ‘next chapter’

cafead

Administrator
Staff member
  • cafead   Sep 16, 2024 at 10:22: PM
via Warner Biddle and Christi Shaw, two prominent former executives at Gilead’s CAR-T division, will try to turn around an autoimmune cell therapy developer that’s lost most of its value since raising $319 million in a February IPO.

article source
 

<